Evidence map›Paper›PMID 30728220›Full record

ArticleDiabetes care2019

Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A

Joshua M Evron, William H Herman, Laura N McEwen

Erratum issuedAbstract read
In one paragraph

Article in Diabetes care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Pitfalls of HbA1c in the Diagnosis of Diabetes.The Journal of clinical endocrinology and metabolism · 2020
    Article
  13. Article
  14. The Oral Glucose Tolerance Test: 100 Years Later.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Joshua M EvronDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI.
William H HermanDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-0502-674X
Laura N McEwenDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI lmattei@umich.edu.ORCID 0000-0002-1737-1161

Funding

Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
NIDDK NIH HHS P30 DK092926
6 · The paper itself

Abstract

objectiveScreening involves the presumptive identification of asymptomatic individuals at increased risk for unrecognized disease. We examined changes in screening practices for prediabetes and diabetes since January 2010, when HbA RESEARCH DESIGN AND

methodsWe studied members without diabetes of an HMO ≥45 years of age continuously enrolled for ≥3 years and assigned to primary care clinicians affiliated with a large academic health system. We defined screening as the first oral glucose tolerance test, HbA

resultsOf 12,772 eligible patients, 9,941 (78%) were screened at least once over 3 years. HbA

conclusionsAs we observed in 2004, rates of screening are high. HbA

Indexed as

Mass ScreeningAdultAgedAged, 80 and overBlood GlucoseDiabetes MellitusFemaleGlucose Tolerance TestGlycated HemoglobinGuideline AdherenceHumansMaleMiddle AgedPractice Guidelines as TopicPractice Patterns, Physicians'Prediabetic StateBlood GlucoseGlycated Hemoglobin

Identifiers

PMID30728220
PMCPMC7373494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.